Frank Burgaezy, Roger Durst, and Bernard Kolodziej were all named executive vice presidents at Bruker AXS last week. The newly appointed executive management team will be responsible for all aspects of the firm's business, including global sales and marketing, customer support, manufacturing, research and development, operations and financial management, the company said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.